Stay updated on Efficacy of Pexidartinib in TGCT Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Pexidartinib in TGCT Clinical Trial page.

Latest updates to the Efficacy of Pexidartinib in TGCT Clinical Trial page
- Check4 days agoChange DetectedReleased a new v3.0.2 with 2025 dates and an estimated last-update label; older 2024 entries and the Back to Top link were removed.SummaryDifference0.9%
- Check11 days agoChange DetectedThe web page has been updated to include a new publication related to a Phase 3 study of Pexidartinib, which is significant for users interested in the latest research on Tenosynovial Giant Cell Tumor. Additionally, the version number has been updated from v3.0.0 to v3.0.1.SummaryDifference3%
- Check18 days agoChange DetectedThe web page has updated its facility name and location details, while also removing specific location terms and certain medical conditions. Additionally, the version has been revised from v2.16.12 to v3.0.0.SummaryDifference1%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12, indicating a revision in the content.SummaryDifference0.1%
- Check39 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check47 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.9%
Stay in the know with updates to Efficacy of Pexidartinib in TGCT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Pexidartinib in TGCT Clinical Trial page.